Dacarbazine, Vincristine, Bleomycin and Lomustine plus Natural Interferon-alpha for Metastatic Melanoma

By Reinhold U.   Bruske T.   Kreysel H.W.  

European Journal of Cancer, Vol. 32, Iss. 1, 1996-01 ,pp. : 180-180

Elsevier

Access to resources Recommend Favorite

Economic analysis of adjuvant therapy with interferon alpha-2a in stage II malignant melanoma

By Lafuma A.   Dreno B.   Delaunay M.   Emery C.   Fagnani F.   Hieke K.   Bonerandi J.-J.   Grob J.-J.   for the French Cooperative Group on Melanoma  

European Journal of Cancer, Vol. 37, Iss. 3, 2001-02 ,pp. : 369-375

Elsevier

Access to resources Recommend Favorite

Ifosfamide, mesna, and interferon-alpha2A combination chemoimmunotherapy in malignant mesothelioma: Results of a single center in Central Anatolia

By Altinbas Mustafa   Er Ozlem   Ozkan Metin   Coskun Hasan   Gulmez Inci   Ekici Eyup   Kaplan Bunyamin   Eser Bulent   Ozesmi Mustafa  

Medical Oncology, Vol. 21, Iss. 4, 2004-12 ,pp. : 359-366

Humana Press, Inc

Access to resources Recommend Favorite

Brain metastases following interleukin-2 plus interferon-alpha-2a therapy - a follow-up study in 94 stage IV melanoma patients

By Schmittel A.   Proebstle T.   Engenhart-Cabillic R.   Scheibenbogen C.   Geueke A.-M.   Thiel E.   Keilholz U.  

European Journal of Cancer, Vol. 39, Iss. 4, 2003-03 ,pp. : 476-480

Elsevier

Access to resources Recommend Favorite

The Role of the CTLA4 Blockade in the Treatment of Malignant Melanoma

By Cranmer Lee   Hersh Evan  

Cancer Investigation, Vol. 25, Iss. 7, 2007-10 ,pp. : 613-631

Informa Healthcare

Access to resources Recommend Favorite